Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07469670 · ClinicalTrials.gov registry record
Nasal Swab Objective and Statistical Evaluation (NOSE Study)
A clinical trial of SARS Coronavirus 2 RT-PCR Testing, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 1,179
- Enrollment target
- 1
- Study location
NCT07469670: Completed study of SARS Coronavirus 2 RT-PCR Testing, sponsored by VA Office of Research and Development.
NCT07469670 is a study of SARS Coronavirus 2 RT-PCR Testing that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,179 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07469670, a study of SARS Coronavirus 2 RT-PCR Testing, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 1,179 participants
- Enrollment target
- 1
- Study location
Study Summary
Supply chain disruptions have led to shortages in test swabs which are used to collect respiratory samples. Lack of these test swabs can reduce a hospital or state's ability to test patients for COVID-19. To address this shortage, many manufacturers, hospitals and individuals have designed non-traditional 3D printed swabs for COVID-19 diagnosis that could potentially meet demands for nasal swabs. However, questions regarding the safety and effectiveness of these swabs remain. This study will provide additional, statistically supported evidence as to the safety and efficacy of novel swabs.
Primary Outcome
Ability for the alternative swab to correctly predict a positive test result from the standard of care swab (1st swab)
Conditions Studied
Study Locations (1)
Washington
- VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,179 participants |
| Start Date | 2021-04-05 |
| Est. Completion | 2022-08-16 |
What the finished NCT07469670 record still lists
NCT07469670 is an observational study that tracks outcomes without assigning an intervention. Its 1,179 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with SARS Coronavirus 2 RT-PCR Testing appearing as the primary indexed condition, and to 0 interventions.
NCT07469670 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT07469670 about?
NCT07469670 is a clinical study titled "Nasal Swab Objective and Statistical Evaluation (NOSE Study)". Supply chain disruptions have led to shortages in test swabs which are used to collect respiratory samples. Lack of these test swabs can reduce a hospital or state's ability to test patients for COVID-19. To address this shortage, many manufacturers, hospitals and individuals have designed non-trad...
What is the current status of trial NCT07469670?
This trial is currently completed. The enrollment target is 1,179 participants. The study started on 2021-04-05. Estimated completion is 2022-08-16.
What conditions does trial NCT07469670 study?
This clinical trial studies the following conditions: SARS Coronavirus 2 RT-PCR Testing.
Who is sponsoring clinical trial NCT07469670?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07469670 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05688436 · 1,178 participants
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
- NCT06931275 · 1,178 participants · NA
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- NCT06133322 · 1,176 participants · NA
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI